about
Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal gangliaEnrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeImpact of sepsis on CD4 T cell immunityPersistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tractPathogenesis of varicelloviruses in primatesTopical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeZoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge.T-lymphocyte Subsets as a Prognostic Factor in a Clinical Course of Chickenpox.T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients.Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.T-cell responses to KSHV infection: a systematic approach.Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques.Varicella and herpes zoster vaccine development: lessons learned.Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency.
P2860
Q27333997-831336EF-41DF-436F-A4BE-2A020DFEC270Q33870372-2E14108A-C43E-46CF-9D82-DFC3D7A513C4Q33916162-ADDDBB42-9AE0-4116-AFED-4B5459BEE92CQ34341378-24E407A1-40D0-45D4-9D15-A9A1DD93BD74Q34681733-0C65F7D4-4C2A-45BA-B2C2-C03E5E1797FDQ34714480-D6A4A783-1AB9-43C7-AB0C-BD774F6E1825Q34992660-7AD7C81C-0291-4CB4-929A-7EE3B7D438B1Q36024466-79985C5B-BA34-4BBF-8970-DF772AD69A1AQ36931965-648D8259-D4F5-4A5A-A91F-B91D66FFF740Q37544128-83B45945-E157-4464-9DB2-C653BB302D53Q40220736-1C554796-1BA5-4427-BF64-01181798667DQ40442389-D871FF2E-0DDA-4517-AFCC-44D73AC06887Q40721567-AF18BB13-D2A0-416F-9E3A-4CEEFA2B7777Q41928445-61DB4B76-AAA6-4498-BE3F-AC1200569698Q42149711-85EC239A-7A33-4892-9762-D5A48CF8D9E8Q47136517-649F33E4-7AD6-4C02-A55A-A42579AB21B8Q47339827-26EAC68D-6644-4F2F-B1A6-CB698C6EABBCQ47556867-F5D49C40-C5F7-4CF5-B3A7-0B615A266655Q47563232-BC25AE14-0C3A-4F19-9BE6-2C9951BD271CQ47607699-A1B0C77A-B2CB-40BE-9609-1187C508E622Q54241403-7A9B98D5-09DB-4CB8-BE4B-D7BB435852B7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T-cell immunity to human alphaherpesviruses.
@en
T-cell immunity to human alphaherpesviruses.
@nl
type
label
T-cell immunity to human alphaherpesviruses.
@en
T-cell immunity to human alphaherpesviruses.
@nl
prefLabel
T-cell immunity to human alphaherpesviruses.
@en
T-cell immunity to human alphaherpesviruses.
@nl
P2860
P1476
T-cell immunity to human alphaherpesviruses.
@en
P2093
Georges M G M Verjans
Werner J D Ouwendijk
P2860
P304
P356
10.1016/J.COVIRO.2013.04.004
P577
2013-05-08T00:00:00Z